J3401 Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
Short descriptor: Vyjuvek 5x10^9pfu/ml, 0.1 ml
Look up J3401 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J3401 is the HCPCS Level II code for Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2024-01-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes
- Dose / Unit
- per 0.1 ml
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J3401 with the canonical source and edition:
J3401 — Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J3401
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J3401